Suppr超能文献

苯丁酸钠通过一种替代途径改善氮的排泄,而不会在对照和鸟氨酸转氨甲酰酶缺乏症患者中引起蛋白质分解和分解代谢的增加。

Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.

机构信息

US Department of Agriculture/Agricultural Research Service Children's Nutrition Research Center, Departments of Pediatrics and Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.

出版信息

Am J Clin Nutr. 2011 Jun;93(6):1248-54. doi: 10.3945/ajcn.110.009043. Epub 2011 Apr 13.

Abstract

BACKGROUND

Phenylbutyrate is a drug used in patients with urea cycle disorder to elicit alternative pathways for nitrogen disposal. However, phenylbutyrate administration decreases plasma branched-chain amino acid (BCAA) concentrations, and previous research suggests that phenylbutyrate administration may increase leucine oxidation, which would indicate increased protein degradation and net protein loss.

OBJECTIVE

We investigated the effects of phenylbutyrate administration on whole-body protein metabolism, glutamine, leucine, and urea kinetics in healthy and ornithine transcarbamylase-deficient (OTCD) subjects and the possible benefits of BCAA supplementation during phenylbutyrate therapy.

DESIGN

Seven healthy control and 7 partial-OTCD subjects received either phenylbutyrate or no treatment in a crossover design. In addition, the partial-OTCD and 3 null-OTCD subjects received phenylbutyrate and phenylbutyrate plus BCAA supplementation. A multitracer protocol was used to determine the whole-body fluxes of urea and amino acids of interest.

RESULTS

Phenylbutyrate administration reduced ureagenesis by ≈15% without affecting the fluxes of leucine, tyrosine, phenylalanine, or glutamine and the oxidation of leucine or phenylalanine. The transfer of (15)N from glutamine to urea was reduced by 35%. However, a reduction in plasma concentrations of BCAAs due to phenylbutyrate treatment was observed. BCAA supplementation did not alter the respective baseline fluxes.

CONCLUSIONS

Prolonged phenylbutyrate administration reduced ureagenesis and the transfer of (15)N from glutamine to urea without parallel reductions in glutamine flux and concentration. There were no changes in total-body protein breakdown and amino acid catabolism, which suggests that phenylbutyrate can be used to dispose of nitrogen effectively without adverse effects on body protein economy.

摘要

背景

苯丁酸钠是一种用于尿素循环障碍患者的药物,可诱导氮排泄的替代途径。然而,苯丁酸钠的给药会降低血浆支链氨基酸(BCAA)的浓度,先前的研究表明,苯丁酸钠的给药可能会增加亮氨酸的氧化,这表明蛋白质降解和净蛋白丢失增加。

目的

我们研究了苯丁酸钠给药对健康和鸟氨酸转氨甲酰酶缺陷(OTCD)受试者全身蛋白质代谢、谷氨酰胺、亮氨酸和尿素动力学的影响,以及在苯丁酸钠治疗期间补充 BCAA 的可能益处。

设计

7 名健康对照和 7 名部分 OTCD 受试者以交叉设计接受苯丁酸钠或无治疗。此外,部分 OTCD 和 3 名完全 OTCD 受试者接受苯丁酸钠和苯丁酸钠加 BCAA 补充。使用多示踪剂方案来确定尿素和感兴趣的氨基酸的全身通量。

结果

苯丁酸钠给药使尿素生成减少约 15%,而不影响亮氨酸、酪氨酸、苯丙氨酸或谷氨酰胺的通量以及亮氨酸或苯丙氨酸的氧化。来自谷氨酰胺的(15)N 向尿素的转移减少了 35%。然而,由于苯丁酸钠治疗,观察到血浆 BCAA 浓度降低。BCAA 补充并没有改变各自的基线通量。

结论

长期苯丁酸钠给药可减少尿素生成和(15)N 从谷氨酰胺向尿素的转移,而谷氨酰胺通量和浓度没有平行减少。全身蛋白质分解和氨基酸分解代谢没有变化,这表明苯丁酸钠可有效地处理氮,而不会对身体蛋白质代谢产生不利影响。

相似文献

2
Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
Mol Genet Metab. 2004 Apr;81 Suppl 1:S79-85. doi: 10.1016/j.ymgme.2003.11.017.
3
In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.
J Clin Invest. 1996 Nov 1;98(9):2167-73. doi: 10.1172/JCI119023.
4
Acute effects of phenylbutyrate on glutamine, branched-chain amino acid and protein metabolism in skeletal muscles of rats.
Int J Exp Pathol. 2017 Jun;98(3):127-133. doi: 10.1111/iep.12231. Epub 2017 Jun 16.
5
6
Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency.
Metabolism. 1993 Oct;42(10):1336-9. doi: 10.1016/0026-0495(93)90135-b.
7
8
Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders.
Mol Genet Metab. 2014 Sep-Oct;113(1-2):131-5. doi: 10.1016/j.ymgme.2014.06.005. Epub 2014 Jul 3.

引用本文的文献

1
Monitoring the treatment of urea cycle disorders using phenylbutyrate metabolite analyses: Still many lessons to learn.
Mol Genet Metab. 2023 Nov;140(3):107699. doi: 10.1016/j.ymgme.2023.107699. Epub 2023 Sep 11.
2
Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency.
J Inherit Metab Dis. 2021 May;44(3):618-628. doi: 10.1002/jimd.12347. Epub 2020 Dec 30.
3
Ex Vivo Enteroids Recapitulate In Vivo Citrulline Production in Mice.
J Nutr. 2018 Sep 1;148(9):1415-1420. doi: 10.1093/jn/nxy126.
4
Single amino acid supplementation in aminoacidopathies: a systematic review.
Orphanet J Rare Dis. 2014 Jan 13;9:7. doi: 10.1186/1750-1172-9-7.
5
Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.
Neurotherapeutics. 2013 Oct;10(4):688-97. doi: 10.1007/s13311-013-0217-2.

本文引用的文献

1
Phenylbutyrate therapy for maple syrup urine disease.
Hum Mol Genet. 2011 Feb 15;20(4):631-40. doi: 10.1093/hmg/ddq507. Epub 2010 Nov 23.
2
Cross-sectional multicenter study of patients with urea cycle disorders in the United States.
Mol Genet Metab. 2008 Aug;94(4):397-402. doi: 10.1016/j.ymgme.2008.05.004. Epub 2008 Jun 17.
3
Manipulation of citrulline availability in humans.
Am J Physiol Gastrointest Liver Physiol. 2007 Nov;293(5):G1061-7. doi: 10.1152/ajpgi.00289.2007. Epub 2007 Sep 27.
4
Leucine and protein synthesis: mTOR and beyond.
Nutr Rev. 2007 Mar;65(3):122-9. doi: 10.1111/j.1753-4887.2007.tb00289.x.
5
Acute depletion of plasma glutamine increases leucine oxidation in prednisone-treated humans.
Clin Nutr. 2007 Apr;26(2):231-8. doi: 10.1016/j.clnu.2006.09.010. Epub 2006 Nov 13.
6
Arginase induction by sodium phenylbutyrate in mouse tissues and human cell lines.
Mol Genet Metab. 2007 Jan;90(1):37-41. doi: 10.1016/j.ymgme.2006.07.002. Epub 2006 Aug 28.
7
Considerations in the difficult-to-manage urea cycle disorder patient.
Crit Care Clin. 2005 Oct;21(4 Suppl):S19-25. doi: 10.1016/j.ccc.2005.05.001.
8
Observations of branched-chain amino acid administration in humans.
J Nutr. 2005 Jun;135(6 Suppl):1580S-4S. doi: 10.1093/jn/135.6.1580S.
9
The role of leucine in the regulation of protein metabolism.
J Nutr. 2005 Jun;135(6 Suppl):1553S-6S. doi: 10.1093/jn/135.6.1553S.
10
Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
Mol Genet Metab. 2004 Apr;81 Suppl 1:S79-85. doi: 10.1016/j.ymgme.2003.11.017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验